All News

Patients can apply topical skin treatments in moderation before radiation therapy despite common advice from health care providers not to, according to study findings published in JAMA Oncology.

People with slow-growing B-cell lymphomas and no symptoms are often prescribed a watch-and-wait approach, which involves monitoring until the disease grows and warrants treatment.

Treating older patients who have Hodgkin lymphoma with Adcetris (brentuximab vedotin) before and after chemotherapy showed improved remission and survival rates, according to phase 2 study findings.

Cancer can affect all areas of life, in both good and bad ways.

The mammogram can be an emotional roller coaster for any person. After you have been diagnosed with breast cancer, even good results can tap into deep emotions.

I stepped out of my comfort zone to share my cancer story.

A cancer diagnosis can bring many fears and uncertainties to the forefront, but it can also bring friendships with people we would never have met had we not gotten cancer at all.

Though it's a weird thing to say, I'm posting this to help you realize that if you "miss having cancer," you're not the only one.

The Food and Drug Administration has granted a priority review to the supplemental new drug application for Jakafi (ruxolitinib) to treat patients with acute graft-versus-host-disease (GVHD) who have had an inadequate response to corticosteroids.

The Food and Drug Administration (FDA) has granted a priority review to a supplemental new drug application for Lonsurf (TAS-102; trifluridine/tipiracil) for use in previously treated patients with advanced or metastatic gastric adenocarcinoma, including cancer of the gastroesophageal junction.

The replacement of vincristine with Velcade (bortezomib) in the R-CHOP regimen for the treatment of transplantation-ineligible patients with newly diagnosed mantle cell lymphoma improved overall survival in a final analysis of the LYM-3002 trial.

After seeing encouraging phase 1 results, the phase 2 portion of a clinical trial currently evaluating the efficacy of the BET inhibitor CPI-0610 in patients with myelofibrosis has been enhanced and expanded.

For many patients with polycythemia vera, hydroxyurea is a beneficial first-line treatment. But that’s not the case for everyone. One expert discusses which drugs should be used next.

The immunotherapy agent Keytruda is showing promise for treating non-muscle invasive bladder cancer, according to a recent study.

Advice for the inoperable facing a lifetime of treatment.

Understanding the type of MPN can affect how care is carried out and how well it may work.

A recent study found that fatigue reported among newly diagnosed patients with multiple myeloma may predict survival outcomes.

Preliminary findings showed that Revlimid (lenalidomide) significantly prolonged progression-free survival compared with observation in patients with smoldering multiple myeloma.

The anti-PD-1 monoclonal antibody TSR-042 may be safe and effective for the treatment of patients with microsatellite-high (MSI-H) endometrial cancer.

A blood test may help to identify a subset of patients with mantle cell lymphoma and determine the management of outcomes of these individuals.

While cancer can strip or challenge our life roles and identity, I hope we all remember that we are more than a patient, more than a statistic, and that we can learn something new about ourselves.

After two of my oncologists retired, I had to search for the next one.

After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.

When Paul Isenberg’s wife, Nicole, was diagnosed with stage 4 Hodgkin lymphoma shortly after the birth of their child, Gabrielle, the couple realized two things: how blessed they were and that some people going through cancer have nobody to turn to.

A high dose of precision radiation could drastically increase the survival rates of patients with metastatic cancer, and double the time patients live without cancer growth, according to study results presented at the 60th Annual Meeting of the American Society for Radiation Oncology.

In a recent survey, individuals in remission reported a more positive experience with bladder cancer compared with their counterparts who currently have active disease.

Breast cancer survivor who had treatment years ago discusses her new breast cancer choices today.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

I walked my way through the Spartan Race in 2016, battled cancer later that year, and returned the the Spartan course in 2018.